Magseed Pro(R)/ Sentimag(R) Gen3 — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Magseed Pro(R)/ Sentimag(R) Gen3 — Stella

Recruiting

Back to Breast Cancer trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(6 sites)

Germany

Marienhospital Bottrop GmbH, Bottrop

AGAPLESION Markus Frankfurter Diakonie Kliniken gGmbH, Frankfurt

Technical University Munich, Munich

United Kingdom

Guy's Hospital, London

Royal Marsden Hospital, London

Key details

Sponsor

Endomagnetics Ltd.

Enrollment target

~224 participants

Started

March 2023

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated September 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov